RxDoctor Payments Data

Cassandra Brewster, MD

Family Medicine · Harrisonville, MONPI 1801826193

Payments from drug & device makers

$2,906in general payments, 2019–2025

Across 171 payments — averaging $16.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$557
  • Pfizer$441
  • Novo Nordisk$373
  • AstraZeneca$177
  • Lilly USA, LLC$168
  • Dexcom, Inc.$155
  • plus $1K from 31 others

What the payments were for

  • Food & beverage$2,89199%
  • Education$151%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,906 in reported general payments places this provider in the 80th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$76,179
Medicare patients
298
Services billed
935

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide92$140,119
EliquisApixaban57$77,412
JardianceEmpagliflozin59$72,222
JanuviaSitagliptin Phosphate79$65,778
MounjaroTirzepatide41$43,563
XareltoRivaroxaban20$24,371
ArexvyRsvpref3 Antigen/As01e/Pf85$22,854
Tresiba Flextouch U-100Insulin Degludec22$19,749
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$18,725
Breo ElliptaFluticasone/Vilanterol12$12,411
Spiriva RespimatTiotropium Bromide13$8,919
TradjentaLinagliptin12$6,114
Levothyroxine Sodium586$5,143
Fluticasone-SalmeterolFluticasone Propion/Salmeterol24$5,111
Omeprazole375$4,985

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$373$140,11992 claims
Boehringer IngelheimJardiance, Spiriva Respimat, Tradjenta$44$87,25484 claims
PfizerEliquis, Paxlovid$441$78,84177 claims
MerckJanuvia$14$65,77879 claims
GSKArexvy, Trelegy Ellipta, Breo Ellipta$29$53,990119 claims
Lilly USA, LLCMounjaro$168$43,56341 claims
Johnson & JohnsonXarelto$19$24,37120 claims
AbbVieSynthroid$557$2,31925 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Harrisonville

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →